151 related articles for article (PubMed ID: 1492611)
1. Potential role of HBGF (FGF) and TGF-beta on prostate growth.
Matuo Y; McKeehan WL; Yan GC; Nikolaropoulos S; Adams PS; Fukabori Y; Yamanaka H; Gaudreau J
Adv Exp Med Biol; 1992; 324():107-14. PubMed ID: 1492611
[TBL] [Abstract][Full Text] [Related]
2. Heparin-binding fibroblast growth factors and prostate cancer.
McKeehan WL; Hou J; Adams P; Wang F; Yan GC; Kan M
Adv Exp Med Biol; 1993; 330():203-13. PubMed ID: 7690178
[TBL] [Abstract][Full Text] [Related]
3. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
Byrne RL; Leung H; Neal DE
Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
[TBL] [Abstract][Full Text] [Related]
4. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts.
Story MT; Hopp KA; Meier DA; Begun FP; Lawson RK
Prostate; 1993; 22(3):183-97. PubMed ID: 7683814
[TBL] [Abstract][Full Text] [Related]
5. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.
Barrack ER
Prostate; 1997 Apr; 31(1):61-70. PubMed ID: 9108888
[TBL] [Abstract][Full Text] [Related]
6. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
[TBL] [Abstract][Full Text] [Related]
7. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration.
Kan M; Huang JS; Mansson PE; Yasumitsu H; Carr B; McKeehan WL
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7432-6. PubMed ID: 2477840
[TBL] [Abstract][Full Text] [Related]
8. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
9. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
[TBL] [Abstract][Full Text] [Related]
10. Studies on the pathogenesis of osteoblastic metastases by prostate cancer.
Goltzman D; Bolivar I; Rabbani SA
Adv Exp Med Biol; 1992; 324():165-71. PubMed ID: 1283497
[No Abstract] [Full Text] [Related]
11. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites.
Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD
Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723
[TBL] [Abstract][Full Text] [Related]
12. Upregulated expression of fibroblast growth factor (FGF) receptors by transforming growth factor-beta1 (TGF-beta1) mediates enhanced mitogenic responses to FGFs in cultured human lung fibroblasts.
Thannickal VJ; Aldweib KD; Rajan T; Fanburg BL
Biochem Biophys Res Commun; 1998 Oct; 251(2):437-41. PubMed ID: 9792792
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
[TBL] [Abstract][Full Text] [Related]
14. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
[TBL] [Abstract][Full Text] [Related]
15. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor).
Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
18. Regulation of prostatic growth and function by peptide growth factors.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
[TBL] [Abstract][Full Text] [Related]
19. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
